The Sunday Times Features Luxury Fertility Concierge IMA ART's Co-Founders Michelle Tang & Ron Sonnenberg
The Feature Article, written by Megan Agnew, highlights IMA ART's transformative approach to Luxury Fertility & Surrogacy for Discerning Clientele.
BEVERLY HILLS, CA / ACCESSWIRE / September 17, 2024 / IMA ART, the world's premier luxury fertility concierge, was recently featured in The Sunday Times Magazine. The article, titled "Want a Girl with Blue Eyes? Inside California's VIP IVF Industry," was published on September 15, 2024, and offers an exclusive glimpse into the extraordinary services provided by IMA ART's co-founders, Michelle Tang and Ron Sonnenberg, for discerning clientele of ultra-high-net-worth individuals.
Megan Agnew's feature underscores IMA ART's revolutionary bespoke approach to fertility and surrogacy, spotlighting the boutique white-glove fertility concierge offered to the select few who engage their services. As the only Fertility Maison, IMA ART limits its annual clientele, meticulously curating every aspect of the fertility concierge and surrogacy process, from selecting Reproductive Endocrinologists and private nurses, to designing a personalized experience for each client. Every aspect of their clients' arrival in Los Angeles, from exclusive dining reservations and luxury accommodations to seamless transportation, are meticulously curated.
During the interview, Tang and Sonnenberg emphasized the rigorous selection process for surrogates, ensuring not only their physical well-being but also the safety and environment in which they live. "We assess everything, from cleanliness to the neighborhood," Sonnenberg shared. Once a match is made, IMA ART customizes every element of the surrogacy arrangement, from diet and lifestyle preferences to home care, ensuring optimal conditions for both surrogate and baby.
The article also touches on IMA ART's full-service, white-glove approach, from providing private medical consultations to scheduling appointments with Beverly Hills' top fertility clinics. IMA ART's concierge service, ranging from $30,000 to $85,000+ offers unmatched support and guidance, ensuring that every detail is handled with discretion and precision.
Michelle Tang adds, "Our clients expect the highest level of care and detail, and that's exactly what we provide, from the beginning of the journey to the birth of their child." As a testament to their commitment, the firm provides surrogates with housekeepers, random alcohol testing upon client request, and even organizes "twin" births through coordinated surrogate pregnancies.
IMA ART's presence in the fertility space redefines luxury fertility & surrogacy, seamlessly blending privacy, exclusivity, and exceptional service.
About IMA ART
The World's First & Only White-Glove Luxury Fertility Concierge & Surrogacy Agency, nestled in the heart of Beverly Hills. The private firm is a sanctuary of bespoke advisory services offering discreet fertility solutions to an exclusive clientele. The Fertility Maison has redefined the journey for discerning clients expecting savoir-faire of excellence.
Known for its luxurious approach & strict confidentiality, it stands as a paradigm shift in Haute Fertility.
Contact Information
Ron Sonnenberg
Co-Founder
ron@imaartfertility.com
(424)-284-1408
SOURCE: IMA ART
View the original press release on newswire.com.
IMAART LLC

Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
BioFi's Phēnix X Family Expands: Revolutionary Phēnix XT, (Phēnix X Tablet), Enters CE Testing Phase, Paving the Way for Global Launch28.4.2025 18:00:00 EEST | Press release
WELDON SPRING, MO / ACCESS Newswire / April 28, 2025 / Finnovant Inc., a leading innovator in biometric authentication and blockchain solutions, is proud to announce a new and innovative Tablet. the Phēnix XT, the latest addition to the groundbreaking Phēnix Family of devices, has completed countrywide evaluations, and has officially entered the CE testing phase. This critical step is anticipated to be completed by June 15, 2025, moving the Phēnix XT closer to global availability. The introduction of the Phēnix XT marks an amazing new development for the Phēnix X platform, opening up a huge opportunity globally, particularly for numerous educational and business applications. Designed to complement the Phēnix X phone and platform, the tablet brings a larger form factor and enhanced capabilities to the secure, decentralized ecosystem. Following successful CE Certification, the Phēnix XT Tablet will be submitted for Type Approval testing in all countries where the Phēnix X phone has alre
BioFi's Revolutionary Phēnix X Blockchain Phone Achieves 4G Type Approval and Certification, Paving the Way for Nigerian Launch28.4.2025 17:00:00 EEST | Press release
WELDON SPRING, MO / ACCESS Newswire / April 28, 2025 / Finnovant Inc., a trailblazing fintech company specializing in mobile technology and biometric authentication solutions, proudly announces that its revolutionary Phēnix X Blockchain phone has successfully attained the coveted 4G Type Approval certification in Nigeria. This significant milestone ensures seamless compatibility with mobile networks across Nigeria and paves the way for launches in other markets across Africa, Southeast Asia, and South America. The BioFi team is thrilled by this achievement as it prepares for the impending launch in the Nigerian market, on the heels of the Nigerian Communications Commissions (NCC) Approvals. The Phēnix X is poised to revolutionize user experiences in Nigeria and other markets, offering advanced security, deep blockchain integration, immersive training capabilities, integrated partner content, and cutting-edge technological advancements. As a leading advocate and pioneer in mobile Blockc
Finnovant Inc. and Storage Chain Announce Industry-First PhenixLoc Data Manager Launch, Bringing Unprecedented Security and Innovative Features with Affordable Decentralized Storage to Emerging Markets28.4.2025 16:00:00 EEST | Press release
MOUNTAIN VIEW, CA / ACCESS Newswire / April 28, 2025 / Finnovant, a leader in mobile technology and biometric authentication solutions, and Storage Chain, a pioneer in decentralized storage technology, today announced the upcoming launch of the PhēnixLoc Data Manager, set for June 1, 2025. This groundbreaking product utilizing Web 3 technology is poised to revolutionize data security and accessibility, particularly for underbanked and unbanked individuals in emerging markets, offering an industry-first combination of advanced security, user control, and affordability on Android, iOS, and through Browsers on any device. The PhēnixLoc Data Manager provides encrypted, decentralized storage for all types of private or sensitive information. Built with the specific needs of emerging markets in mind, it delivers incredible security and pricing designed to be accessible and affordable for anyone. Access to PhēnixLoc is through Web 3 decentralized technology and secured by Say-Tec, Finnovant's
Progressive Supranuclear Palsy Phase 2 Platform Clinical Trial Announces the Selection of AADvac1 and AZP2006 for its First Two Regimens28.4.2025 15:00:00 EEST | Press release
LONDON, GB / ACCESS Newswire / April 28, 2025 / The Progressive Supranuclear Palsy (PSP) Trial Platform (PTP), led by Drs. Adam Boxer (University of California, San Francisco [UCSF]), Irene Litvan (University of California, San Diego), Julio Rojas (UCSF) and Anne-Marie Wills (Massachusetts General Hospital), has selected two promising drug candidates-Axon Neuroscience's AADvac1 and Alzprotect's AZP2006-for inclusion in the platform trial as the first two compounds to be evaluated. The trial aims to accelerate the development of effective treatments for PSP, a rare and fatal neurodegenerative disease. Additional compounds to be evaluated in the trial are expected to be announced later this year. Funded by the National Institute on Aging (NIA), part of the U.S. National Institutes of Health (NIH), the platform trial is supported by a five-year grant. Its design enables multiple therapies to be tested concurrently, establishing a perpetual, efficient and flexible path to evaluate promisin
SYNLawn Welcomes Romania’s First Official SYNLawn Distributor27.4.2025 11:00:00 EEST | Press release
POPEŞTI-LEORDENI, RO / ACCESS Newswire / April 27, 2025 / SYNLawn, a global manufacturer and innovator of bio-based synthetic turf, announced its expansion into a new international market with the launch SYNLawn Romania. The company will carry SYNLawn's premium line of synthetic turf and surfacing products as the first official and exclusive distributor in Romania. "Our newest official partner is dedicated to bringing premium artificial turf solutions to the Romanian market," said George Neagle, president of SYNLawn Global. "With a strong focus on landscaping, golf, and commercial applications, SYNLawn Romania is set to redefine outdoor spaces in its region with high-quality, durable, and environmentally friendly artificial grass." The company started its business in 2022 and is based in Popești-Leordeni, just 9 kilometers from Bucharest. SYNLawn Romania specializes in the distribution of premium landscaping products. While new to the artificial turf sector, the company has a solid fou
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom